#ASH25: Eli Lilly's Jaypirca makes first-line case, but ceiling may be capped
#ASH25: Eli Lilly's Jaypirca makes first-line case, but ceiling may be capped
#ASH25: Eli Lilly's Jaypirca makes first-line case, but ceiling may be capped
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.